Interestingly, the tipping point for arthritis development may not be when ACPA first appear [40] but rather at a stage with quality shift, such as glycosylation [41, 42], or specificity changes occurring predominantly in individuals with certain MHC class II alleles [43]. This evidence concerns the gene PRTN3 and Arthritis.